Ignite Creation Date:
2024-10-26 @ 3:42 PM
Last Modification Date:
2024-10-26 @ 3:42 PM
Study NCT ID:
NCT06642272
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-10-10
Brief Title:
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
Status:
RECRUITING
Status Verified Date:
2024-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
APPLE TREE
Brief Summary:
The aim of this clinical trial is investigate the comparative effectiveness of empagliflozin and dapagliflozin for the treatment of diabetes chronic kidney disease and heart failure
Patients who are prescribed either empagliflozin or dapagliflozin as part of daily clinical practice at the participating sites will be included in the study Treatment will be randomized automatically through the electronic health record software in clusters defined by time of day
Patients who are prescribed either empagliflozin or dapagliflozin as part of daily clinical practice at the participating sites will be included in the study Treatment will be randomized automatically through the electronic health record software in clusters defined by time of day
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None